Innovation Institute
-
Read ArticleAI and Cancer treatment
The goal is to create a digital representation—or medical twin—of a patient and use advanced AI to understand what treatments work best and provide more informed options about the most effective paths
-
Read ArticleSpectrum News - St. Joe's - Cardio Genetics Testing
According to the cdc, heart disease is the leading cause of death in America. Going all the way back to the 1950's. and while people have become familiar with genetic testing for cancer risk.
-
Read ArticleNew Prevention4ME Study: Access Matters More Than Outreach in Genetic Screening
Findings suggest that while outreach yields low engagement, low-cost methods such as email are feasible, and point-of-care access is critical for improving participation and equity. Health systems sho
-
Read Article2025 Genomics Annual Report
Read the Latest Genomics Annual Report
-
Read ArticleScaling insights into immunotherapy with GigaTIME
Researchers from Providence, the University of Washington, and Microsoft developed GigaTIME, a publicly available AI model that generates spatial proteomic images at scale.
-
Read ArticleProvidence rolls out toolkit to boost cancer research equity
A research team from Renton, Wash based Providence has launched an interactive toolkit to help health systems boost equity in medical research.
-
Read ArticleProvidence Institute for Clinical Innovation shares how innovation impacts patients
-
Read ArticleNew Study: Why this breakthrough in pig-to-human kidney research matters
A new Providence-led study published in Nature offers one of the most detailed looks yet at what actually happens inside the body after a pig kidney is transplanted into a human.
-
Read ArticleNew Providence study identifies key risk factors for early-onset colorectal Cancer
A Cross-Sectional Retrospective Case-Control Study on Predictors of Early Onset Colorectal Cancer in a Multi-State Community Health System.
-
Read ArticleGeno4ME Study Show How Whole Genome Sequencing May Impact Routine Genetic Screening
Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible
-
Read ArticleProvidence whole genome sequencing program could help transform population health
-
Read ArticleNew AI Model Shows Potential for Revolutionizing Clinical Trials and Generating Real World Evidence
New research recently published in the New England Journal of Medicine begs the question: Can an AI-based model revolutionize clinical research?
-
Read ArticleProvidence whole genome sequencing program shows transformative potential for population health
A new study from researchers at Providence, published in Nature NPJ Genomic Medicine, demonstrates how Whole Genome Sequencing (WGS) can transform health care
-
Read ArticleProvidence weighs in: How genetic testing is reshaping everyday care
Genetic testing has moved beyond academic centers to being reflected in clinical guidelines adopted by a growing number of clinicians
-
Read ArticleTwo immune patterns help predict how head and neck cancer patients respond to immunotherapy
New Providence research published in Nature-Precision Oncology finds that in head and neck cancer, researchers found that two specific immune response patterns
-
Read ArticleIntroducing BiomedParse: A new AI foundation model for faster, smarter, all-in-one image analysis
A wide variety of medical imaging tools (CT,MRI, pathology etc.) are used in routine medical care, and represent robust datasets for potential biomedical discovery using Artificial Intelligence (AI)
-
Read ArticleBreak through Research Early sequencing offers a 67% chance of changing treatments and improved survival.
Research from a team led by Brian Piening, PhD, Program Director for Providence Genomics that included colleagues from across Providence as well as collaborators at Illumina and Microsoft
-
Read ArticleEarly Detection for More Patients: Prevention4ME expands and includes more data
Prevention4ME has identified more than 2600 patients at high risk for cancer who are now being screened differently or receiving NCCN guideline-recommended genetic testing
-
Read ArticleProvidence launches groundbreaking study to elevate real-world use of multi-cancer early detection
Providence Genomics and Providence-Swedish Cancer Institute have launched the PREVAIL study,
-
Read ArticleComprehensive Genomic Profiling leads to better patient outcomes, a new joint study says
Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System
-
Loading More...
